本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

再鼎医药

40.51
+1.824.70%
盘后40.35-0.1600-0.39%18:16 EDT
成交量:144.51万
成交额:5,851.91万
市值:44.80亿
市盈率:-16.33
高:41.20
开:40.96
低:39.79
收:38.69
数据加载中...
2021/01/11

重要事件披露

8-K - Current report
2021/01/06

重要事件披露

8-K - Current report
2021/01/04

重要事件披露

8-K - Current report
2020/12/09

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/09/18

SEC问询函

CORRESP [Cover] - Correspondence
2020/09/18

[修订]年度报告

20-F/A [Amend] - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2020/08/13

财报披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/06/17

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2020/04/29

年度报告

Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2020/04/08

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/19

财报披露

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/16

非美公司披露报告

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/14

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/14

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/14

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/13

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/11

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/07

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/03

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/01/27

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]